Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Steroids
|
December 12, 2002
Estrogen receptor phosphorylation
Deborah A Lannigan
Endocrinology
|
July 26, 2022
ERK1/2-RSK2 Signaling in Regulation of ERα-Mediated Responses
Deborah A Lannigan
The FEBS Journal
|
February 17, 2022
ERK1/2-RSK regulation of oestrogen homeostasis
Eric B Wright, Deborah A Lannigan
The Journal of Cell Biology
|
August 25, 2010
A chromatin-bound kinase, ERK8, protects genomic integrity by inhibiting HDM2-mediated degradation of the DNA clamp PCNA
Angela L Groehler, Deborah A Lannigan
Frontiers in Cell and Developmental Biology
|
January 3, 2024
Therapeutic targeting of p90 ribosomal S6 kinase
Eric B Wright, Deborah A Lannigan
Expert Opinion on Therapeutic Patents
|
July 14, 2016
Ribosomal S6 kinase (RSK) modulators: a patent review
Katarzyna A Ludwik, Deborah A Lannigan
Molecular & Cellular Oncology
|
November 25, 2020
RSK2 and ERα comrades-in-arms in homeostasis and transformation
Katarzyna A Ludwik, Deborah A Lannigan
Expert Opinion on Therapeutic Targets
|
December 5, 2024
RSK1 and RSK2 as therapeutic targets: an up-to-date snapshot of emerging data
Ashley N Spirrison, Deborah A Lannigan
The Journal of Steroid Biochemistry and Molecular Biology
|
June 30, 2005
Novel biosensors for the detection of estrogen receptor ligands
Siddhartha De, Ian G Macara, Deborah A Lannigan
Steroids
|
January 5, 2010
RSK in tumorigenesis: connections to steroid signaling
T S Karin Eisinger-Mathason, Josefa Andrade, Deborah A Lannigan
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Steroids
|
December 12, 2002
Estrogen receptor phosphorylation
Deborah A Lannigan
Endocrinology
|
July 26, 2022
ERK1/2-RSK2 Signaling in Regulation of ERα-Mediated Responses
Deborah A Lannigan
The FEBS Journal
|
February 17, 2022
ERK1/2-RSK regulation of oestrogen homeostasis
Eric B Wright, Deborah A Lannigan
The Journal of Cell Biology
|
August 25, 2010
A chromatin-bound kinase, ERK8, protects genomic integrity by inhibiting HDM2-mediated degradation of the DNA clamp PCNA
Angela L Groehler, Deborah A Lannigan
Frontiers in Cell and Developmental Biology
|
January 3, 2024
Therapeutic targeting of p90 ribosomal S6 kinase
Eric B Wright, Deborah A Lannigan
Expert Opinion on Therapeutic Patents
|
July 14, 2016
Ribosomal S6 kinase (RSK) modulators: a patent review
Katarzyna A Ludwik, Deborah A Lannigan
Molecular & Cellular Oncology
|
November 25, 2020
RSK2 and ERα comrades-in-arms in homeostasis and transformation
Katarzyna A Ludwik, Deborah A Lannigan
Expert Opinion on Therapeutic Targets
|
December 5, 2024
RSK1 and RSK2 as therapeutic targets: an up-to-date snapshot of emerging data
Ashley N Spirrison, Deborah A Lannigan
The Journal of Steroid Biochemistry and Molecular Biology
|
June 30, 2005
Novel biosensors for the detection of estrogen receptor ligands
Siddhartha De, Ian G Macara, Deborah A Lannigan
Steroids
|
January 5, 2010
RSK in tumorigenesis: connections to steroid signaling
T S Karin Eisinger-Mathason, Josefa Andrade, Deborah A Lannigan
Page
of 4